Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-8 of 8 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
1999Evaluation of the dose-response relationship for intra-nasal oxymetazoline hydrochloride in normal adultsTaverner, D.; Bickford, L.; Shakib, S.; Tonkin, A.
2007The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after single increasing oral doses in healthy malesSargentini-Maier, M.; Rolan, P.; Connell, J.; Tytgat, D.; Jacobs, T.; Pigeolet, E.; Riethuisen, J.; Stockis, A.
2009The acceptability, safety, and tolerability of methadone/naloxone in a 50:1 ratioBell, J.; Shearer, J.; Ryan, A.; Graham, R.; Korompay, K.; Rizzo, S.; Sindhusake, D.; Somogyi, A.
2008Enhanced buprenorphine analgesia with the addition of ultra-low-dose naloxone in healthy subjectsLa Vincente, S.; White, J.; Somogyi, A.; Bochner, F.; Chapleo, C.
1999The nasal airways response in normal subjects to oxymetazoline spray: randomized double-blind placebo-controlled trialBickford, L.; Shakib, S.; Taverner, D.
2004A randomized, double-blind, placebo-controlled trial of pseudoephedrine in coryzaLatte, G.; Taverner, D.; Slobodian, P.; Shakib, S.
2012The effects of pregabalin and the glial attenuator minocycline on the response to intradermal capsaicin in patients with unilateral sciaticaSumracki, N.; Hutchinson, M.; Gentgall, M.; Briggs, N.; Williams, D.; Rolan, P.; Ikeda, K.
2002Pharmacokinetics, pharmacodynamics, safety, and tolerability of a single-dose of NN2211, a long-acting glucagon-like peptide 1 derivative, in healthy male subjectsElbrond, B.; Jakobsen, G.; Larsen, S.; Agerso, H.; Jensen, L.; Rolan, P.; Sturis, J.; Hatorp, V.; Zdravkovic, M.